The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), potassium chloride oral solution USP, 40 mEq/15 mL (20 per cent) of Genus Lifesciences Inc, it added.
Genus's Generic Chlorpromazine Hydrochloride Receives ApprovalIn US
Enforcement Report - Week of January 20, 2021